Literature DB >> 12710683

TP53, hChk2, and the Li-Fraumeni syndrome.

Jenny Varley1.   

Abstract

Germline TP53 mutations are responsible for the large majority of classic LFS families, and a smaller proportion of LFL families. In some of the families shown to have no germline TP53 mutation, germline hChk2 mutations have been described. In some cases the functional consequences of the latter have been demonstrated, although there are still relatively few reports of such mutations. Due to the paucity of families currently described with hChk2 mutations, it is not possible to reach any conclusions concerning the phenotypic/clinical differences between the two types of germline mutation. At least one family with a germline hChk2 mutation is a classic LFS family, whereas others are LFL, variant-LFS, or phenotypically suggestive of LFS. However, there is still a significant number of LFS/LFL families for which no underlying genetic determinant has been identified. It will be fascinating to see what genetic defects are responsible, and whether they involve additional components of DNA damage recognition, repair, or cell cycle checkpoint pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12710683     DOI: 10.1385/1-59259-328-3:117

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Pediatric adrenal cortical carcinoma: brain metastases and relationship to NF-1, case reports and review of the literature.

Authors:  Aaron Scott Wagner; Julie M Fleitz; B K Kleinschmidt-Demasters
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

2.  Childhood adrenocortical tumours: a review.

Authors:  Rosana Marques-Pereira; Luiz Delacerda; Hadriano M Lacerda; Edson Michalkiewicz; Fabiano Sandrini; Romolo Sandrini
Journal:  Hered Cancer Clin Pract       Date:  2006-05-15       Impact factor: 2.857

Review 3.  Review: Ewing Sarcoma Predisposition.

Authors:  Pablo Gargallo; Yania Yáñez; Antonio Juan; Vanessa Segura; Julia Balaguer; Bárbara Torres; Silves Oltra; Victoria Castel; Adela Cañete
Journal:  Pathol Oncol Res       Date:  2019-10-26       Impact factor: 3.201

4.  Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.

Authors:  Steve Heymann; Suzette Delaloge; Arslane Rahal; Olivier Caron; Thierry Frebourg; Lise Barreau; Corinne Pachet; Marie-Christine Mathieu; Hugo Marsiglia; Céline Bourgier
Journal:  Radiat Oncol       Date:  2010-11-08       Impact factor: 3.481

5.  Case Report: Exome sequencing reveals recurrent RETSAT mutations and a loss-of-function POLDIP2 mutation in a rare undifferentiated tongue sarcoma.

Authors:  Jason Y K Chan; Peony Hiu Yan Poon; Yong Zhang; Cherrie W K Ng; Wen Ying Piao; Meng Ma; Kevin Y Yip; Amy B W Chan; Vivian Wai Yan Lui
Journal:  F1000Res       Date:  2018-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.